COMMUNIQUÉS West-GlobeNewswire

Lotus Facility Construction & Commissioning Update

27/07/2018 - 17:01

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- ARMSTRONG FACILITY Construction of Lotus’ initial production [...]

MannKind and Tanner Pharma Group Enter into an ex-U.S. Distribution Agreement for Afrezza®

27/07/2018 - 15:37

WESTLAKE VILLAGE, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such [...]

Coherus BioSciences Receives Positive CHMP Opinion for UDENYCA™ (Pegfilgrastim Biosimilar Candidate)

27/07/2018 - 15:36

REDWOOD CITY, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has [...]

MannKind Corporation to Hold 2018 Second Quarter Financial Results Conference Call on August 2, 2018

27/07/2018 - 15:00

WESTLAKE VILLAGE, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will host a conference call to discuss the 2018 second quarter and year-to-date financial results and other corporate [...]

Aeroponics Can Change Cannabis Cultivation -- CFN Media

27/07/2018 - 15:00

SEATTLE, July 27, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]

BlissCo Advances E-Commerce Program Ahead of Cannabis Legalization -- CFN Media

27/07/2018 - 15:00

SEATTLE, July 27, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]

ContraFect Corporation Prices $10 Million Public Offering of Common Stock

27/07/2018 - 15:00

YONKERS, N.Y., July 27, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug- [...]

BioCryst to Announce Second Quarter 2018 Financial Results on August 7

27/07/2018 - 15:00

RESEARCH TRIANGLE PARK, N.C., July 27, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today that its second quarter 2018 financial results will be reported on Tuesday, August 7, 2018. [...]

Sandoz receives European Commission approval for biosimilar Hyrimoz® (adalimumab)

27/07/2018 - 14:54

Biosimilar Hyrimoz ® (adalimumab) approved for use in all same indications as reference medicine ** * including rheumatology, gastroenterology and dermatology Early therapeutic intervention is essential in rheumatoid [...]

Curriculum Vitae of Lauris Macijevskis a newly elected Board member of AS Olainfarm

27/07/2018 - 14:45

CURRICULUM VITAE of Lauris Macijevskis Name, Surname: Lauris Macijevskis Education: 2004 - 2006 Riga International School of Economics and Business Administration, diploma for higher professional education - Master in [...]

Cellectar Biosciences Announces Pricing of $14.4 Million Underwritten Public Offering

27/07/2018 - 14:30

MADISON, Wis., July 27, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB) (“Cellectar” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization [...]

Ultragenyx to Host Conference Call for Second Quarter 2018 Financial Results and Corporate Update

27/07/2018 - 14:30

NOVATO, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]

Tetraphase Pharmaceuticals Receives Positive CHMP Opinion for Xerava™ (eravacycline) as a Treatment for Complicated Intra-Abdominal Infections

27/07/2018 - 14:30

WATERTOWN, Mass., July 27, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]

CHMP Issues Positive Opinion Recommending DARZALEX® (daratumumab) for Front Line Multiple Myeloma

27/07/2018 - 14:28

Company Announcement CHMP issued positive opinion for DARZALEX for front line multiple myeloma Final decision from European Commission expected in the coming months Opinion based on data from Phase III ALCYONE study [...]

Novartis combination Tafinlar® + Mekinist® receives positive CHMP opinion for adjuvant treatment of BRAF V600 mutation-positive melanoma

27/07/2018 - 14:25

Phase III trial showed a 53% reduction in risk of recurrence or death with the combination of a BRAF and MEK inhibitor as adjuvant therapy versus placebo[1] Relapse-free survival benefit with Tafinlar + Mekinist [...]

Status of the Market Authorisation Application of Apealea in the European Union

27/07/2018 - 14:25

Oasmia Pharmaceutical AB hereby issues a notification that contrary to what was anticipated in the draft agenda for this month’s meeting by the Committee for Medicinal Products for Human Use (CHMP), there was no oral [...]

European CHMP Maintains Negative Opinion on Portola Pharmaceuticals’ Betrixaban Following Appeal

27/07/2018 - 14:24

SOUTH SAN FRANCISCO, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines [...]

Sun Biopharma, Inc. Presents Poster at Pancreasfest in Pittsburgh, Pa.

27/07/2018 - 14:00

Results of Phase 1 Safety Study of SBP-101 for Pancreatic Ductal Adenocarcinoma PancreasFest is an International Conference of Physicians and Scientists Focused on Pancreatic Diseases MINNEAPOLIS, MN, July 27, 2018 ( [...]

Delcath Amends Phase 3 Ocular Melanoma Trial Protocol

27/07/2018 - 14:00

Revision to Nonrandomized (Single Arm) Study Reduces Trial Size Enrollment Requirement Enrollment Anticipated to be Completed by First Half 2019 NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: [...]